Lawstreet Journal

India and Pfizer in a deadlock, efforts to resolve the stalemate over an indemnity clause for vaccine side effects underway

Lawstreet Journal 27 May 2021 8:38pm

Image courtesy: Lawstreet Journal Executive India and Pfizer in a deadlock, efforts to resolve the stalemate over an indemnity clause for vaccine side effects underway

Pfizer and the government of India are seeking to resolve the impasse over the demand by the US drugmaker for legal protection from any claims linked to the use of its COVID-19 vaccine in Indian markets.

India is still in talks with Pfizer over the indemnity clause that provides immunity against compensation to the drugmaker for any severe side effects, which is a condition Pfizer has obtained in all the other countries where its shots have been used and administered, including Britain and the United States of America.

The Indian government is in a fix and it is crucial for the government to resolve the stalemate and reach an agreement as the country struggles to secure the required dosage of vaccine with the tally of more than 2,00,000 Covid cases looming over the heads of the authority, propping routinely.

In the light of the incessant rising of cases in the country with a population of over 1.3 billion people, it can be inferred that the number of vaccinated people roughly touching 19 crores will inevitably raise concern over the humongous population that still remains unvaccinated in the backdrop of limited vaccine production.

Indian foreign minister plans to visit the United States in the coming weeks, a source cited and he could also offer Pfizer some protection from lawsuits in exchange for the distribution of its vaccine in India. However, the same is yet to be confirmed by the Indian Foreign Ministry.

Another issue being discussed between the drug manufacturing company and the government was… Continue Reading...


Tagged: Corona Updates   Pfizer  
Disclaimer: SoOLEGAL in Media collaboration with Lawstreet Journal. SoOLEGAL take no responsbility for the content provided by Lawstreet Journal. For any discrepancies Contact Lawstreet Journal.
Did you find this write up useful? YES 0 NO 0
×

C2RMTo Know More

Something Awesome Is In The Work

0

DAYS

0

HOURS

0

MINUTES

0

SECONDS

Sign-up and we will notify you of our launch.
We’ll also give some discount for your effort :)

* We won’t use your email for spam, just to notify you of our launch.
×

SAARTHTo Know More

Launching Soon : SAARTH, your complete client, case, practise & document management SAAS application with direct client chat feature.

If you want to know more give us a Call at :+91 98109 29455 or Mail info@soolegal.com